ARCT
Price
$6.79
Change
-$0.01 (-0.15%)
Updated
Nov 28 closing price
Capitalization
192.92M
Intraday BUY SELL Signals
RPTX
Price
$2.18
Change
-$0.03 (-1.36%)
Updated
Nov 28 closing price
Capitalization
93.71M
93 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ARCT vs RPTX

Header iconARCT vs RPTX Comparison
Open Charts ARCT vs RPTXBanner chart's image
Arcturus Therapeutics Holdings
Price$6.79
Change-$0.01 (-0.15%)
Volume$302.01K
Capitalization192.92M
Repare Therapeutics
Price$2.18
Change-$0.03 (-1.36%)
Volume$128.57K
Capitalization93.71M
ARCT vs RPTX Comparison Chart in %
ARCT
Daily Signal:
Gain/Loss:
RPTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ARCT vs. RPTX commentary
Nov 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARCT is a StrongBuy and RPTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 30, 2025
Stock price -- (ARCT: $6.79 vs. RPTX: $2.18)
Brand notoriety: ARCT and RPTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARCT: 20% vs. RPTX: 22%
Market capitalization -- ARCT: $192.92M vs. RPTX: $93.71M
ARCT [@Biotechnology] is valued at $192.92M. RPTX’s [@Biotechnology] market capitalization is $93.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARCT’s FA Score shows that 0 FA rating(s) are green whileRPTX’s FA Score has 0 green FA rating(s).

  • ARCT’s FA Score: 0 green, 5 red.
  • RPTX’s FA Score: 0 green, 5 red.
According to our system of comparison, RPTX is a better buy in the long-term than ARCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARCT’s TA Score shows that 5 TA indicator(s) are bullish while RPTX’s TA Score has 6 bullish TA indicator(s).

  • ARCT’s TA Score: 5 bullish, 3 bearish.
  • RPTX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both ARCT and RPTX are a good buy in the short-term.

Price Growth

ARCT (@Biotechnology) experienced а +8.47% price change this week, while RPTX (@Biotechnology) price change was +3.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.92%. For the same industry, the average monthly price growth was +1.16%, and the average quarterly price growth was +72.91%.

Reported Earning Dates

RPTX is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+6.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARCT($193M) has a higher market cap than RPTX($93.7M). RPTX YTD gains are higher at: 66.412 vs. ARCT (-59.988). ARCT has higher annual earnings (EBITDA): -54.54M vs. RPTX (-110.47M). ARCT has more cash in the bank: 196M vs. RPTX (109M). RPTX has less debt than ARCT: RPTX (649K) vs ARCT (27M). ARCT has higher revenues than RPTX: ARCT (110M) vs RPTX (250K).
ARCTRPTXARCT / RPTX
Capitalization193M93.7M206%
EBITDA-54.54M-110.47M49%
Gain YTD-59.98866.412-90%
P/E RatioN/AN/A-
Revenue110M250K44,000%
Total Cash196M109M180%
Total Debt27M649K4,160%
FUNDAMENTALS RATINGS
ARCT: Fundamental Ratings
ARCT
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
12

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARCTRPTX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 6 days ago
83%
Declines
ODDS (%)
Bearish Trend 10 days ago
87%
Bearish Trend 10 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ARCT
Daily Signal:
Gain/Loss:
RPTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PEYUF15.990.35
+2.25%
Peyto Exploration & Development Corp
NETWF0.09N/A
N/A
Network Media Group Inc.
RRDMF0.13N/A
N/A
Royal Road Minerals Limited
ANTVF5.92N/A
N/A
Antares Vision SRL SPA
VDMCY7.79-0.21
-2.57%
Vodacom Group Ltd.

RPTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RPTX has been loosely correlated with INO. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if RPTX jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPTX
1D Price
Change %
RPTX100%
-1.36%
INO - RPTX
51%
Loosely correlated
+5.10%
BCYC - RPTX
50%
Loosely correlated
+2.33%
CADL - RPTX
42%
Loosely correlated
+3.25%
LVTX - RPTX
40%
Loosely correlated
N/A
ALNY - RPTX
38%
Loosely correlated
+1.37%
More